Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits

May 29, 2020 updated by: ADIR Association

Pulmonary rehabilitation (PR) has proven its efficacy to improve dyspnea, health status, exercise tolerance and quality of life for patients with stable Chronic Obstructive Pulmonary Disease (COPD). Exercise training has previously been thoroughly studied but education has been less studied in PR. Furthermore, only few studies have investigated the added value of an educational program (EP) to exercise training on clinical and physical factors. Characterizing those patients who refuse EP is therefore a first step to better target them and potentially improve their adherence and outcome following PR.

The aim of this study was to determine the characteristics of the COPD patients referred to PR who refused EP compare to those who accepted and to identify the independent predictive factors of refusal. The investigators also sought to compare the change in clinical outcomes and number and length of hospitalization at six months following PR among those patients who accepted or not to participate in EP.

Study Overview

Study Type

Observational

Enrollment (Actual)

201

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bois-Guillaume, France
        • ADIR Association

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients referred for pulmonary rehabilitation between July 2015 and July 2019 to ADIR Association, Rouen University Hospital, France

Description

Inclusion Criteria:

  • Clinical diagnosis of COPD,
  • >18 years old,
  • Stable state of COPD.

Exclusion Criteria:

  • Patients who have not been offered an educational program
  • Patients who have already been offered an educational program during a pulmonary rehabilitation in the same center.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ETEP group
Exercise Training and Educational Program (ETEP) group. Patients who accepted the educational program in addition to the exercise training.

The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not.

The EP consisted of an educational diagnosis, educational workshops and an individual final assessment.

ET group
Exercise Training (ET) group. Patients who refused the educational program and did only the exercise training.

The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not.

The EP consisted of an educational diagnosis, educational workshops and an individual final assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multiple logistic regression between the variables defined and the refusal of educational program
Time Frame: Baseline
The variables are described below in primary outcomes
Baseline
Gender
Time Frame: Baseline
Gender will be analysed in logistic regression.
Baseline
Age
Time Frame: Baseline
Age will be analysed in logistic regression.
Baseline
Height
Time Frame: Baseline
Height will be analysed in logistic regression.
Baseline
Weight
Time Frame: Baseline
Weight will be analysed in logistic regression.
Baseline
Body mass index
Time Frame: Baseline
Body mass index will be analysed in logistic regression.
Baseline
COPD stages
Time Frame: Baseline
COPD stages will be analysed in logistic regression.
Baseline
Forced Expiratory Volume in one second
Time Frame: Baseline
Forced Expiratory Volume in one second will be analysed in logistic regression.
Baseline
Forced Vital Capacity
Time Frame: Baseline
Forced Vital Capacity will be analysed in logistic regression.
Baseline
Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity
Time Frame: Baseline
Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity will be analysed in logistic regression.
Baseline
Total Lung Capacity
Time Frame: Baseline
Total Lung Capacity will be analysed in logistic regression.
Baseline
Residual Volume
Time Frame: Baseline
Residual Volume will be analysed in logistic regression.
Baseline
Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume
Time Frame: Baseline
Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume will be analysed in logistic regression.
Baseline
Comorbidities
Time Frame: Baseline
Comorbidities will be analysed in logistic regression.
Baseline
Tabacco status
Time Frame: Baseline
Tabacco status will be analysed in logistic regression.
Baseline
Tabacco consumption
Time Frame: Baseline
Tabacco consumption will be analysed in logistic regression.
Baseline
Prescription of oxygen
Time Frame: Baseline
Prescription of oxygen will be analysed in logistic regression.
Baseline
Prescription of non invasive ventilation
Time Frame: Baseline
Prescription of non invasive ventilation will be analysed in logistic regression.
Baseline
Arterial oxygen partial pressure
Time Frame: Baseline
Arterial oxygen partial pressure will be analysed in logistic regression.
Baseline
Arterial carbon dioxide partial pressure
Time Frame: Baseline
Arterial carbone dioxide partial pressure will be analysed in logistic regression.
Baseline
Location of the training sessions
Time Frame: Baseline
Location of the training sessions will be analysed in logistic regression.
Baseline
Ambulance transport
Time Frame: Baseline
Number of patients with an ambulance transport will be analysed in logistic regression.
Baseline
Distance between patient's home and center
Time Frame: Baseline
Distance between patient's home and center will be analysed in logistic regression.
Baseline
Dyspnea
Time Frame: Baseline
Dyspnea assessed by the modified Medical Research Council scale will be analysed in logistic regression.
Baseline
6-Minute Stepper Test
Time Frame: Baseline
Number of steps during the 6-Minute Stepper Test will be analysed in logistic regression.
Baseline
6-Minute Walk Test
Time Frame: Baseline
Distance during the 6-Minute Walk Test will be analysed in logistic regression.
Baseline
Maximal oxygen consumption
Time Frame: Baseline
Maximal oxygen consumption during cardiopulmonary exercise testing will be analysed in logistic regression.
Baseline
Maximal workload
Time Frame: Baseline
Maximal workload achieved during cardiopulmonary exercise testing will be analysed in logistic regression.
Baseline
Saint George's Respiratory Questionnaire
Time Frame: Baseline
Quality of life assessed by Saint George's Respiratory Questionnaire will be analysed in logistic regression.
Baseline
Employment
Time Frame: Baseline
Employment will be analysed in logistic regression.
Baseline
Educational level
Time Frame: Baseline
Educational level assessed by the international classification "Classification Internationale Type de l'Education" will be analysed in logistic regression.
Baseline
Cognitive impairment
Time Frame: Baseline
Cognitive impairment assessed by the Montreal Cognitive Assessment will be analysed in logistic regression.
Baseline
Anxiety and depression level
Time Frame: Baseline
Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-Minute Stepper Test
Time Frame: 2 months
Change in number of steps during the 6-Minute Stepper Test will be compared between groups.
2 months
6-Minute Walk Test
Time Frame: 2 months
Change in distance during the 6-Minute Walk Test will be compared between groups.
2 months
Saint George's Respiratory Questionnaire
Time Frame: 2 months
Change in Saint George's Respiratory Questionnaire will be compared between groups.
2 months
Anxiety and depression level
Time Frame: 2 months
Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.
2 months
Cognitive impairment
Time Frame: 2 months
Change in cognitive impairment assessed by the Montreal Cognitive Assessment will be compared between groups.
2 months
Number of hospitalizations
Time Frame: 6 months
Number of hospitalizations will be compared between groups.
6 months
Number of hospitalized patients
Time Frame: 6 months
Number of hospitalized patients will be compared between groups.
6 months
Number of days of hospitalization
Time Frame: 6 months
Number of days of hospitalization will be compared between groups.
6 months
Attendance rate at educational sessions
Time Frame: 2 months
Attendance rate at education sessions will be analysed
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jean-François Muir, MD PhD, ADIR Association, Rouen University Hospital, Rouen, France;Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France
  • Study Chair: Antoine Cuvelier, MD PhD, Normandie University, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France ; Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.
  • Study Chair: David Debeaumont, MD, Department of Respiratory and Exercise Physiology and CICCRB 1404, Rouen University Hospital, Rouen France.
  • Study Chair: Tristan Bonnevie, PT MSc, ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France.
  • Study Chair: Francis-Edouard Gravier, PT MSc, ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France
  • Study Chair: Pauline Smondack, PT, ADIR Association, Rouen University Hospital, Rouen, France.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2020

Primary Completion (Actual)

March 31, 2020

Study Completion (Actual)

April 10, 2020

Study Registration Dates

First Submitted

March 6, 2020

First Submitted That Met QC Criteria

March 9, 2020

First Posted (Actual)

March 10, 2020

Study Record Updates

Last Update Posted (Actual)

June 1, 2020

Last Update Submitted That Met QC Criteria

May 29, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Educational program

3
Subscribe